Table 5.
Sample | Cytotoxic Activity (GI50, µg/mL) | ||||
---|---|---|---|---|---|
MCF-7 | NCI-H460 | HeLa | HepG2 | PLP2 | |
B1 | 30 ± 1 d | 27 ± 2 g | 24 ± 1 c | 21 ± 2 de | 61 ± 2 c |
B2 | 24 ± 1 e | 20.5 ± 0.9 h | 23 ± 1 cd | 25 ± 2 c | 41 ± 1 e |
B3 | 58 ± 4 b | 53 ± 2 c | 44.2 ± 0.4 b | 36 ± 1 b | 80 ± 3 b |
B4 | 38 ± 3 c | 47 ± 1 d | 20 ± 2 de | 23 ± 1 cd | 51 ± 1 d |
B5 | 42 ± 3 c | 40.7 ± 1.5 e | 16 ± 1 g | 45 ± 4 a | 52 ± 1 d |
B6 | 24.5 ± 1.2 e | 33.5 ± 1.0 f | 20 ± 1 ef | 15 ± 1 ef | 41 ± 4 e |
B7 | 87 ± 4 a | 89 ± 8 a | 9.3 ± 0.5 h | 18 ± 2 e | 95 ± 2 a |
B8 | 8 ± 1 h | 8.7 ± 0.4 j | 10.0 ± 0.3 h | 13 ± 1 fg | 17.9 ± 1.5 h |
B9 | 10.1 ± 0.3 h | 40 ± 1 e | 9 ± 1 h | 11.1 ± 0.4 gh | 42 ± 2 e |
B10 | 16 ± 1 g | 16 ± 1 hi | 10 ± 1 h | 16 ± 1 ef | 24.1 ± 2.5 g |
B11 | 7.1 ± 0.5 h | 15.0 ± 0.4 i | 11 ± 1 h | 13 ± 1 fg | 17.1 ± 1.5 h |
B12 | 10 ± 1 h | 10 ± 1 j | 18 ± 2 fg | 9.1 ± 0.4 h | 21 ± 2 gh |
B13 | 9.0 ± 0.8 h | 12 ± 1 ij | 9.0 ± 0.4 h | 9 ± 1 h | 17 ± 2 h |
B14 | 19 ± 1 fg | 15 ± 1 i | 16 ± 1 g | 16 ± 1 ef | 30.5 ± 1.1 f |
B15 | 22 ± 1 ef | 26 ± 1 g | 20.5 ± 1.5 de | 17 ± 1 e | 48 ± 2 d |
B16 | 62 ± 1 b | 76 ± 1 b | 51 ± 3 a | 38 ± 3 b | 95 ± 2 a |
Ellipticine | 1.21 ± 0.02 | 0.9 ± 0.1 | 1.0 ± 0.1 | 1.10 ± 0.09 | 2.3 ± 0.2 |
Results are expressed as mean ± standard deviation. In each column, different letters correspond to significant differences (p < 0.05) between samples. GI50 values correspond to the extract concentration responsible for 50% of cell growth inhibition.